Supriya Lifescience Share Price
852.85+10.15 (+1.20%)
+28.76% past 1 Year
News
Supriya Lifescience GM held in judicial custody amid Customs NDPS probe
Equity
SUPRIYA
Supriya Lifescience sets over Rs 1000 crore revenue goal by FY27
Equity
SUPRIYA
Supriya Lifescience reports Profit after tax of 74.23 Crores, in the March 2026 quarter
Equity
SUPRIYA
Supriya Lifescience Q4 EBITDA rises sharply year-on-year amid softer margins
Equity
SUPRIYA
Supriya Lifescience Q4 profit and revenue surge strongly on yearly basis
Equity
SUPRIYA
Supriya Lifescience informs about updates
Equity
SUPRIYA
Supriya Lifescience gets EIR for manufacturing facility at Lote
Equity
SUPRIYA
Supriya Lifescience USFDA Inspection Concludes with One Minor VAI at Manufacturing Facility.
Equity
SUPRIYA
Supriya Lifescience USFDA Inspection Concludes with One Minor VAI at Manufacturing Facility.
Equity
SUPRIYA
Investor Madhu Kela Increases Stake by 0.4% in Supriya Lifescience in Q4.
Equity
SUPRIYA
Supriya Lifescience informs about transcript of earnings Call
Equity
SUPRIYA
Supriya Lifescience Q3 FY26 Results: 11% Revenue Growth, 9% EBITDA Rise, Margins Dip Slightly.
Equity
SUPRIYA
Supriya Lifescience Q3 FY26 Results: Net Profit Up 6% YoY to Rs 49.70 Crores, Revenue Rises 10.8% to Rs 206 Crores.
Equity
SUPRIYA
Supriya Lifescience reports Profit after tax of 49.67 Crores, in the December 2025 quarter
Equity
SUPRIYA
Supriya Lifescience moves higher on aiming up to Rs 1,600 crore revenue in next three years
Equity
SUPRIYA
Supriya Lifescience aims up to Rs 1,600 crore revenue in next three years
Equity
SUPRIYA
Supriya Lifescience guides for Q2FY26 growth, robust EBITDA margin, increased API focus, and export expansion
Equity
SUPRIYA
Supriya Lifescience reports Profit after tax of 50.43 Crores, in the September 2025 quarter
Equity
SUPRIYA
Supriya Lifescience Q2 FY25: EBITDA rises YoY, margin contracts; sector-defining export strength.
Equity
SUPRIYA
Supriya Lifescience posts strong Q2 FY25 results with robust YoY profit and revenue growth
Equity
SUPRIYA